ARCT FY 2019 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M+32.0% YoY

Gross Profit

$21M100.0% margin

Operating Income

-$26M-122.7% margin

Net Income

-$26M-125.0% margin

EPS (Diluted)

$-2.13

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$82M

Total Liabilities

$56M

Stockholders' Equity

$26M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$16M	+32.0%
Gross Profit	$21M	-$1M	+1791.5%
Operating Income	-$26M	-$22M	-17.0%
Net Income	-$26M	-$22M	-19.3%